| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |